Neurobiological Technologies(OTC) NTII

Neurobiological Technologies, Inc. is a biotechnology company based in Emeryville, California, focused on developing experimental pharmaceutical treatments for various human ailments. Currently, the company is undergoing a liquidation and dissolution process, which received stockholder endorsement in October 2009.

Products and Services

• Previously focused on experimental pharmaceutical treatments
• Targeted various human ailments through innovative approaches
• Engaged in research and development in the biotechnology sector

Growth Outlook

• Company's market cap stands at $2,702, indicating potential for growth
• High cash ratio of 25.23 suggests strong liquidity position
• Current ratio of 35.34 indicates robust short-term financial health

Financial Highlights

• Recent quarterly revenue of $6,026,000 demonstrates operational capability
• Net income of $5,405,000 reflects effective cost management
• Gross profit margin of 99.5% indicates strong profitability potential

Neurobiological Technologies, Inc. has a unique position in the biotechnology industry, having previously focused on innovative pharmaceutical solutions. The ongoing liquidation process may present both challenges and opportunities for potential investors. The company's financial metrics, including a high cash ratio and current ratio, suggest a solid liquidity position, which is crucial for navigating its current phase. Recent revenue figures and net income highlight the company's operational capabilities, despite its transition. The high gross profit margin indicates that, historically, the company has been able to maintain profitability, which could be appealing to investors looking for potential recovery or restructuring opportunities.